Integrating IoT & Emerging Technology to Optimise Trials and Patient Outcomes

EVENT HAS NOW PASSED

With 82% of clinical trial experts integrating IoT into their decentralised trials, it is critical for clinical trial, technology, and patient centricity leaders to identify and implement strategies which focus on patient-centred outcomes.

Emerging technology and IoT integrated within decentralised trials can enable data quality, accuracy, and accessibility whilst optimising R&D operations.

However, designing a trial that considers the needs of all stakeholders can be a lengthy process, resulting in high costs and added complexity, accelerating the need for an effective IoT and technology roadmap.

By attending this Summit, you will hear how the European pharma industry is currently leveraging IoT to streamline clinical R&D, enhance patient closeness, and optimise trial effectiveness.

Learn From Our Clinical Trials and Technology Experts

Bert Hartog- Headshot

Bert Hartog, Research and Development Operations, Senior Director,  The Janssen Pharmaceutical Companies of Johnson & Johnson

Terttu Haring- Headshot

Terttu Haring, Global Head for Clinical Digital Innovation, Sanofi

Luis Garcia-Gancedo Headshot

Luis Garcia-Gancedo, Director, Digital Biomarkers, GSK

Nick Carroll- Headshot

Nick Carroll, Executive Director Digital Health Transformation, R&D, AstraZeneca

Amy Apostoleris

Amy Apostoleris, Global Head of Digital Clinical Trials Solutions (DCTS), Medocity

Vanessa Gertsen, Vice President, Study Operations DCT, Care Access

Cristina De Juan, Global Clinical Sciences and Operations Innovation Lead, UCB

Damien Eggenspieler, Healthcare program director, SYSNAV Healthcare

Jonathan Bruno, Senior Project Manager, Digital Medicine and Translational Imaging, Pfizer

Karl-Ludwig Radek, EMEA Strategic Account Lead, Global Clinical Operations, The Janssen Pharmaceutical Companies of Johnson & Johnson

Joss Langford square

Joss Langford, Chief Technical Officer, Activinsights

Richard Dearden- Headshot

Richard Dearden, Head of AI Digital Health, AstraZeneca

Lisa Shafe Headshot 200

Lisa Shafe, Clinical Programme Leader, Roche

Paul deRoulhac- Headshot

Paul deRoulhac, Digital Transformation Lead, Genentech

Steve Yates

Steve Yates, Head of Marketing: EMEA, Egnyte

This event will provide you with the necessary tools to:

  • Ensure you identify and select the right approach  for your patients and company, to improve individual healthcare outcomes and enhance patient experience
  • Simplify the IoT eco-system to avoid overbuilding systems and make clinical trials technology more effective to patient groups and end users
  • Outline the regulatory pathway of GDPR to optimise data management compliance and ensure secure processing of patient data
  • Leverage cross-functional industry collaboration to respond to clinical challenges, advance technology strategy, and enhance future clinical trial design
  • Encourage lasting adoption and evolvement of emerging technology to optimise your R&D and advance clinical trials workforce

IoT Clinical Trials Europe - Agenda

Wednesday 19 January 2022


09:50 – 09:55 CET Opening Remarks from AMG World

 

09:55- 10:25 Need to Know vs Nice to Know: Defining IoT Use Cases to Allow for Successful User Outcomes

 

Presenter:

Bert Hartog, Research and Development Operations, Senior Director, The Janssen Pharmaceutical
Companies of Johnson & Johnson

 

10:30 – 11:00 Getting Closer to the World of the Patient with IoT Thinking 

 

Presenter:

Joss Langford, Chief Technical Officer, Activinsights

 

11:05 – 11:35 Reinventing Mobility Assessment: How Digital Endpoints improve understanding of patient progress. 

 

Presenter:

Damien Eggenspieler, Healthcare program director, SYSNAV Healthcare

 

11:40 – 12:00 Technology Demonstrations

12:00 – 12:30 Networking Lunch and Virtual Exhibition

12:30 – 13:30 Hybrid vs Remote Clinical Trials: Which Approach will Ease Patient Burden

 

Moderator: Steve Yates, Head of Marketing: EMEA, Egnyte

 

Panellists:
Terttu Haring, Global Head for Clinical Digital Innovation, Sanofi
Nick Carroll, Executive Director Digital Health Transformation, R&D, AstraZeneca
Karl Ludwig-Radek, EMEA Strategic Account Lead, Global Clinical Innovations, The Janssen Pharmaceutical Companies of Johnson & Johnson
Vanessa Gertsen, Vice President, Study Operations, Decentralised Clinical Trials, Care Access

 

13:35 – 14:05 Wearables: The Advancement of Digital End Points for Clinical Trial Data

 

Presenter:

Luis Garcia-Gancedo, Director, Digital Biomarkers, GSK


14:10 – 14:40 Evaluating the Impact of Electronic Data Strategy on Decentralised Clinical Trials

14:40 – 15:00 Networking Break and Virtual Exhibition

 

15:00-16:00 Utilising technology to incorporate the patient voice in clinical trials: Where Do We Go Next?

 

Moderator: Amy Apostoleris, Global Head of Digital Clinical Trials Solutions (DCTS), Medocity

 

Panellists:
Cristina De Juan, Global Clinical Sciences and Operations Innovation Lead, UCB
Lisa Shafe, Clinical Programme Lead, Roche
Richard Dearden, Head of AI Digital Health, AstraZeneca
Paul deRoulhac, Digital Transformation Lead, Genentech

 

16:00 Close of the conference

Who Should Attend:

IoT Clinical Trials Europe 2022 is designed for VP’s, Directors, Heads and Managers from:

 

  • Clinical Operations / Intelligence
  • Clinical Innovation / Development / R&D / Technology
  • Digital Health / Medicine / Biomarkers
  • Digital Transformation / Innovation / Operations / Strategy
  • Decentralised Clinical Trials / Hybrid trials / Remote trials
  • Data Management/ Analytics
  • Patient Advocacy / Recruitment / Experience
  • Patient Centred Outcomes
  • Clinical Affairs / Regulatory Affairs / Medical Affairs

Our sponsors include technology, service & solution providers specializing in:

 

  • Wearables/ Biosensors
  • IoT Hardware, Software, Platforms, Infrastructure
  • Data & Analytics
  • Artificial Intelligence (AI) / Machine Learning (ML)
  • ePro solutions
  • e-Source
  • eCOA
  • e-Consent
  • Cloud Computing

2022 Sponsors:

Sponsorship Opportunities:

Recent disruption has continued to re-shape the conventional approach to networking, creating an opportunity to continue business within a virtual setting.

 

Our attendees are actively working through their operational and transformational challenges, but they also require support from dedicated solution providers who can offer guidance, expertise and technology to help solve unique business problems.

 

It is critical that the vendor community continues to support their customers through open discussions and information exchange; as well as nurture existing relationships and building a pipeline of new and valuable leads.

 

For more information on how we are uniquely placed to help you shape and deliver your message to your target audience, contact us now!

 

Simon Wright
Commercial Director
Simon.wright@amg-world.co.uk